• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用健康调整生命年(QALYs)对加利福尼亚州长新冠的负担进行建模。

Modeling the burden of long COVID in California with quality adjusted life-years (QALYS).

机构信息

Division of Communicable Disease Control, California Department of Public Health, Richmond, USA.

Department of Pathology, Microbiology, and Immunology, University of California, Davis, USA.

出版信息

Sci Rep. 2024 Sep 30;14(1):22663. doi: 10.1038/s41598-024-73160-x.

DOI:10.1038/s41598-024-73160-x
PMID:39349557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11443048/
Abstract

Individuals infected with SARS-CoV-2 may develop post-acute sequelae of COVID-19 ("long COVID") even after asymptomatic or mild acute illness. Including time varying COVID symptom severity can provide more informative burden estimates for public health response. Using a compartmental model driven by confirmed cases, this study estimated long COVID burden by age group (0-4, 5-17, 18-49, 50-64, 65+) in California as measured by the cumulative and severity-specific proportion of quality-adjusted life years (QALYs) lost. Long COVID symptoms were grouped into severe, moderate, and mild categories based on estimates from the Global Burden of Disease study, and symptoms were assumed to decrease in severity in the model before full recovery. All 10,945,079 confirmed COVID-19 cases reported to the California Department of Public Health between March 1, 2020, and December 31, 2022, were included in the analysis. Most estimated long COVID-specific QALYs [59,514 (range: 10,372-180,257)] lost in California were concentrated in adults 18-49 (31,592; 53.1%). Relative to other age groups, older adults (65+) lost proportionally more QALYs from severe long COVID (1,366/6,984; 20%). Due to changing case ascertainment over time, this analysis might underestimate the actual total burden. In global sensitivity analysis, estimates of QALYs lost were most sensitive to the proportion of individuals that developed long COVID and proportion of cases with each initial level of long COVID symptom severity (mild/moderate/severe). Models like this analysis can help translate observable metrics such as cases and hospitalizations into quantitative estimates of long COVID burden that are currently difficult to directly measure. Unlike the observed relationship between age and incident severe outcomes for COVID-19, this study points to the potential cumulative impact of mild long COVID symptoms in younger individuals.

摘要

个体感染 SARS-CoV-2 后,即使无症状或轻度急性感染,也可能发展为 COVID-19 的急性后期后遗症(“长新冠”)。包括时间变化的 COVID 症状严重程度可以为公共卫生应对提供更具信息量的负担估计。本研究使用由确诊病例驱动的房室模型,根据加利福尼亚州因质量调整生命年(QALY)损失而导致的累积和严重程度特异性比例,按年龄组(0-4 岁、5-17 岁、18-49 岁、50-64 岁、65+)估计长新冠负担。根据全球疾病负担研究的估计,长新冠症状分为严重、中度和轻度,并且在模型中假设症状在完全恢复之前严重程度会降低。在 2020 年 3 月 1 日至 2022 年 12 月 31 日期间,向加利福尼亚州公共卫生部报告的所有 10,945,079 例 COVID-19 确诊病例均包含在分析中。在加利福尼亚州,估计有 59,514 个(范围:10,372-180,257)长新冠特定 QALY 丢失[59,514(范围:10,372-180,257)],主要集中在 18-49 岁的成年人(31,592;53.1%)。与其他年龄组相比,年龄较大的成年人(65+)因严重长新冠而损失的 QALYs 比例更高(1,366/6,984;20%)。由于随时间推移病例确定发生变化,本分析可能低估了实际的总负担。在全球敏感性分析中,估计的 QALY 丢失对发展为长新冠的个体比例以及每种初始长新冠症状严重程度(轻度/中度/重度)病例比例最敏感。像这样的分析模型可以帮助将可观察到的指标(如病例和住院)转化为目前难以直接测量的长新冠负担的定量估计。与 COVID-19 年龄与发病严重程度之间的观察到的关系不同,本研究指出了轻度长新冠症状在年轻人中潜在的累积影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/42579cf8bc79/41598_2024_73160_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/321f766a3ca5/41598_2024_73160_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/9ee934e5b22d/41598_2024_73160_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/420a05e5fe93/41598_2024_73160_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/42579cf8bc79/41598_2024_73160_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/321f766a3ca5/41598_2024_73160_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/9ee934e5b22d/41598_2024_73160_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/420a05e5fe93/41598_2024_73160_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9113/11443048/42579cf8bc79/41598_2024_73160_Fig4_HTML.jpg

相似文献

1
Modeling the burden of long COVID in California with quality adjusted life-years (QALYS).用健康调整生命年(QALYs)对加利福尼亚州长新冠的负担进行建模。
Sci Rep. 2024 Sep 30;14(1):22663. doi: 10.1038/s41598-024-73160-x.
2
The estimated disease burden of COVID-19 in Japan from 2020 to 2021.2020 年至 2021 年日本 COVID-19 疾病负担估计。
J Infect Public Health. 2023 Aug;16(8):1236-1243. doi: 10.1016/j.jiph.2023.05.025. Epub 2023 May 25.
3
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.意大利接触确诊 SARS-CoV-2 感染患者的密切接触者中,年龄与出现症状和重症疾病的可能性之间的关系。
JAMA Netw Open. 2021 Mar 1;4(3):e211085. doi: 10.1001/jamanetworkopen.2021.1085.
4
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.204 个国家和地区及 811 个次国家级行政单位 1950 年至 2021 年的全球年龄、性别特异性死亡率、预期寿命和人口估计,以及 COVID-19 大流行的影响:2021 年全球疾病负担研究的综合人口分析。
Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11.
5
The Burden of Disease due to COVID-19 in Korea Using Disability-Adjusted Life Years.使用伤残调整生命年来衡量韩国 COVID-19 疾病负担。
J Korean Med Sci. 2020 Jun 1;35(21):e199. doi: 10.3346/jkms.2020.35.e199.
6
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.估计 2020 年和 2021 年有症状 COVID-19 后持续性疲劳、认知和呼吸症状群个体在全球的比例。
JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931.
7
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
8
Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.在 2020 年春季大流行期间估计 SARS-CoV-2 在纽约市的感染病死率:基于模型的分析。
Lancet Infect Dis. 2021 Feb;21(2):203-212. doi: 10.1016/S1473-3099(20)30769-6. Epub 2020 Oct 19.
9
SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study.南非印度马杜赖市首次新冠疫情期间的 SARS-CoV-2 感染和死亡率:一项前瞻性、主动监测研究。
Lancet Infect Dis. 2021 Dec;21(12):1665-1676. doi: 10.1016/S1473-3099(21)00393-5. Epub 2021 Aug 13.
10
The public health and economic burden of long COVID in Australia, 2022-24: a modelling study.2022-2024 年澳大利亚长新冠的公共卫生和经济负担:建模研究。
Med J Aust. 2024 Aug 19;221(4):217-223. doi: 10.5694/mja2.52400.

本文引用的文献

1
Coding long COVID: characterizing a new disease through an ICD-10 lens.长新冠编码:通过 ICD-10 视角描述一种新疾病。
BMC Med. 2023 Feb 16;21(1):58. doi: 10.1186/s12916-023-02737-6.
2
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study.轻度 SARS-CoV-2 感染一年后的长期新冠结局:全国队列研究。
BMJ. 2023 Jan 11;380:e072529. doi: 10.1136/bmj-2022-072529.
3
Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.SARS-CoV-2 感染后 2 年住院与非住院患者的新冠后症状。
JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106.
4
Ascertainment rate of SARS-CoV-2 infections from healthcare and community testing in the UK.英国医疗卫生和社区检测中 SARS-CoV-2 感染的检出率。
J Theor Biol. 2023 Feb 7;558:111333. doi: 10.1016/j.jtbi.2022.111333. Epub 2022 Nov 5.
5
Prevalence and Correlates of Long COVID Symptoms Among US Adults.美国成年人长新冠症状的流行率及相关因素。
JAMA Netw Open. 2022 Oct 3;5(10):e2238804. doi: 10.1001/jamanetworkopen.2022.38804.
6
COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic.COVID 症状、症状群及成为“长新冠”的预测因素——在大流行的迷雾中寻找清晰。
Clin Nurs Res. 2022 Nov;31(8):1390-1398. doi: 10.1177/10547738221125632. Epub 2022 Sep 24.
7
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods - United States, April 2020-June 2022.在奥密克戎和德尔塔变异株流行期间因 COVID-19 住院的患者的死亡率风险 - 美国,2020 年 4 月-2022 年 6 月。
MMWR Morb Mortal Wkly Rep. 2022 Sep 16;71(37):1182-1189. doi: 10.15585/mmwr.mm7137a4.
8
Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.新冠疫苗接种后长新冠症状的轨迹:基于社区的队列研究。
BMJ. 2022 May 18;377:e069676. doi: 10.1136/bmj-2021-069676.
9
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.奥密克戎和德尔塔变异株主导期间感染新型冠状病毒(SARS-CoV-2)个体的症状流行率、持续时间及住院风险:来自ZOE COVID研究的一项前瞻性观察性研究
Lancet. 2022 Apr 23;399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0. Epub 2022 Apr 7.
10
Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort.与 SARS-CoV-2(PASC)在门诊和住院环境中诊断为有症状的 COVID-19 后出现的急性后遗症相关的因素。
J Gen Intern Med. 2022 Jun;37(8):1988-1995. doi: 10.1007/s11606-022-07523-3. Epub 2022 Apr 7.